Cancer

Cancer research spans mechanistic studies of tumor biology, biomarker discovery, diagnostic production, and therapeutic development. Athens provides native human proteins that support work across this spectrum.

Our cancer reagents include proteases implicated in invasion and metastasis, protease inhibitors that regulate tumor progression, and matrix proteins involved in adhesion and angiogenesis—all with native activity preserved.

What sets Athens apart for cancer research:

Tumor-associated proteases – Cathepsins B, D, H, and L from human liver, plus plasmin, plasminogen, and kallikrein from human plasma. Native enzymatic activity verified for functional studies of invasion, metastasis, and extracellular matrix remodeling.

Protease inhibitors and regulatory proteins – Alpha-2 Macroglobulin, Alpha-1 Antitrypsin, and Inter-Alpha Inhibitor Protein for studying the protease-antiprotease balance that influences tumor progression.

Extracellular matrix proteins – Vitronectin and Thrombospondin for research on cell adhesion, migration, and the tumor microenvironment.

Immunoglobulins for cancer diagnostics and research – Complete IgG subclass panel, IgA, IgM, and IgE for assay development, controls, and cancer biomarker research.

Cell culture supplements – Transferrin, Albumin, and lipoproteins for maintaining cancer cell lines and producing therapeutic monoclonal antibodies.